The effect of platelet-rich plasma and corticosteroids in the treatment of plantar fasciitis

Phase 2

Recruiting

• Conditions: M72.2; Plantar fasciitis.; Plantar fascial fibromatosis

• Registration Number: IRCT20220406054429N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age over 18 years
Existence of symptoms for more than 3 months
Plantar fascia thickness above 4 mm on ultrasound examination
VAS score equal to 6 and above

Exclusion Criteria

History of rheumatic diseases
Diabetes or any malignancy
Pregnancy
Bleeding disorders
Sores or infections at the injection site
History of injections during the last 3 months
Taking NSAIDS in the last week
Suspicion of other diagnoses such as fractures or nerve disorders in the area

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plantar fascia thickness. Timepoint: At the beginning of the study and 3 months after the intervention. Method of measurement: Ultrasound device.;Pain. Timepoint: At the beginning of the study and 1 and 3 months after the intervention. Method of measurement: Visual analogue scale questionnaire.;Foot function. Timepoint: At the beginning of the study and 1 and 3 months after the intervention. Method of measurement: Foot and Ankle disability index and Roles and Maudsley score questionnaires.